April 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
Market insights predict, the congenital heart defect devices industry is expected to grow from USD 2.75 billion in 2024 to USD 4.81 billion by 2034, driven by a CAGR of 5.74%. The rising prevalence of congenital heart diseases and technological advancements drive market growth. The growing awareness of prenatal tests and favorable government polici...
April 21, 2026
According to Towards Healthcare research, globally, an increasing number of epilepsy cases, which are demanding effective ASM, along with developments in pharmaceutical companies for novel drugs, are driving the market growth. Whereas, North America experienced dominance due to growing epilepsy prevalence and boosting activities in R&D. ...
April 21, 2026
According to forecasts, the global cell migration and cell invasion assay market will grow from USD 1.84 billion in 2024 to USD 4.1 billion by 2034, with an expected CAGR of 8.34%. The cell migration and cell invasion assay market is growing due to growing research in drug development and oncology. North America is dominating the market due to the ...
April 21, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 21, 2026
The next-generation bispecific antibody market is expanding due to increasing diseases as well as rising autoimmune diseases treatment approaches. North America led the market due to the presence of well-developed industries....
April 21, 2026
Market insights predict, the autoimmune disease diagnostics industry is expected to grow from USD 5.75 billion in 2024 to USD 10.5 billion by 2034, driven by a CAGR of 6.22%. Globally, rising incidences and breakthroughs in technologies in autoimmune disease diagnostics are driving the market expansion. North America led the respective market, due ...
April 21, 2026
Market insights predict, the Europe dermal filler industry is expected to grow from USD 1.84 billion in 2024 to USD 4.23 billion by 2034, driven by a CAGR of 8.84%. The Europe dermal filler market is growing due to rising focus on beauty standards....
April 21, 2026
Based on market forecasts, the healthcare cyber security sector will expand from USD 20.56 billion in 2024 to USD 112.6 billion by 2034, experiencing a CAGR of 18.54%. The market is growing due to the rising threat of data breaches and cyberattacks targeting sensitive patient information. The increasing digitization of health records and the adopti...
April 21, 2026
Based on market forecasts, the primary progressive multiple sclerosis sector will expand from USD 1.29 billion in 2024 to USD 5.11 billion by 2034, experiencing a CAGR of 14.84%. The primary progressive multiple sclerosis market is growing as increased spending in the advanced research of neurodegenerative diseases is significant for discovering no...
April 21, 2026
According to market projections, the global needle free drug delivery devices market, valued at USD 14.24 billion in 2024, is anticipated to reach USD 29.54 billion by 2034, growing at a CAGR of 7.54% over the next decade. The needle free drug delivery devices market is growing due to rising cases of diabetes and to reduce the fear of needles in ch...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com